Stock SABS SAB BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart SAB Biotherapeutics, Inc.

Equities

SABS

US78397T2024

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-06-04 pm EDT 		5-day change 1st Jan Change
2.69 USD +0.75% Intraday chart for SAB Biotherapeutics, Inc. -1.10% -60.87%
May. 30 SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer CI
May. 21 FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SAB BIOTHERAPEUTICS, INC. Stock SAB Biotherapeutics, Inc.
 24.63M - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.82B -
ARGENX SE Stock argenx SE
 22.48B -
GENMAB A/S Stock Genmab A/S
 18.32B
  1. Stock Market
  2. Equities
  3. SABS Stock
  4. Charts SAB Biotherapeutics, Inc.
  5. Sector Chart